mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
HAMBURG, GERMANY, June 20, 2022 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which operates in the German CBD wellbeing and medical cannabis market announces its results for the three months ending March 31st, 2022 (Q1, 2022) and provides an update about the acquisition of CannaCare Health... Read More...
HAMBURG, Germany, May 11, 2022 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health GmbH ("CannaCare"), owner of CANOBO, one of Germany's leading CBD brands announces the appointment of Mr. Frank Otto to the board of... Read More...
This major acquisition immediately strengthens Greenrise's position in the CBD wellness market and builds on Greenrise's strategy to become a leader in the adult-use cannabis market in Germany.
Successful German business leaders Frank Otto and Michael Oplesch have strong backgrounds in the TV, health, and cosmetic industries and have bu... Read More...
AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. LGP medical cannabis products have been registered for sale with the relevant authorities in Germany and include 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes. Doctors and... Read More...
Dronabinol is pure Tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the appropriate authorities in Germany. Doctors and pharmacists can find more information about the product or order on AMP's website: https://amp-eu.com/doccheck-login/
AMP and Eurox entered... Read More...
BERLIN,, Dec. 22, 2021 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") is pleased to provide a year-end letter to its shareholders.
Dear Fellow Shareholders,
Germany's time has come.
The formation of the German government this month confirmed that recreational cannabis for adult use w... Read More...
BERLIN and ERFURT, Germany, Nov. 25, 2021 - Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") would like to comment on the German coalition government's (SPD, Alliance 90/The Greens and FDP) announcement to legalize the sale of cannabis for c... Read More...
Herbify CDB oils are designed to be used orally on a daily basis and contain organic hemp seed oil and CBD extract, essential fatty acids, vitamins, and minerals, as well as herbs, to form an important component of an individual's self-care routine for physical and mental wellbeing.
The Herbify CBD line includes:
Herbify Boost Me conta... Read More...
BERLIN and ERFURT, Germany, Nov. 17, 2021 - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), wholly-owned subsidiary, AMP Alternative Medical Products GmbH ("AMP"), a pharmaceutical supplier of medical cannabis products to German pharmacies, announces the lau... Read More...
BERLIN, Nov. 3, 2021 - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), (the "Company") announces it has acquired Greenrise GmbH ("Greenrise Wellbeing") from its founders, Messrs. Hendrik Knopp, Florian Witt and Alex Hintz. Mr. Hendrik Knopp has been appointed to the board of directors, Mr. Florian ... Read More...
The new cooperation of AMP with Tilray as their sole marketing partner in Germany for the Aphria brand is based on a supply and marketing agreement with CC Pharma GmbH, a wholly-owned subsidiary of Tilray. The conclusion of this agreement is a milestone for AMP in providing a complete catalogue of medical cannabis products for doctors to... Read More...
ERFURT, Germany and BERLIN and STADTBERGEN, Germany, Sept. 13, 2021 - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies, and WaldhausKlinik Deuringen gGmbH ("Waldhausklinik"), a non-profit acute care hospital for internal me... Read More...
AMP created CANAVEX® for cosmetic use and sold exclusively by pharmacists without a doctor's prescription. CANAVEX® formulation includes high quality CBD, which is sourced from Germany and EU-GMP compliant, organic hemp seed oil and vitamin E.
CANAVEX®'s initial products are Basic CBD 5, which contains 500mg or 5% CBD and Basic CBD 10, w... Read More...
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s ("Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"), have entered into a strategic agreement (the "Co-Promoti... Read More...
ERFURT, Germany and BERLIN, Dec. 16, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (Frankfurt: C4T) (ISIN: CA00176G1028) is pleased to provide a letter to its shareholders.
Dear Shareholders,
The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally.
AMP's focus has always b... Read More...
ERFURT, Germany and BERLIN, Nov. 30, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) is proud to present the second episode of its "Round Table" series with Dr. Wieland Schinnenburg, MdB of the FDP, who provides an up-to-date overview of the political issues and challenges facing the medical cannab... Read More...
ERFURT, Germany and BERLIN and ÅRSLEV, Denmark, Nov. 5, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products and Schroll Medical ApS ("Schroll"), a Danish cultivator of medical cannabis, announce that t... Read More...
AMP is looking forward to offering premium EU-GMP full plant extract cannabis oil medicines branded under the LGP Classic brand, produced by the same consistent strains. AMP wants to introduce the LGP brand to the German market by selling "LGP Classic 20:5 Oils" (THC dominant) and additional products in the near term once AMP has establ... Read More...
ERFURT and BERLIN, Germany, Sept. 15, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately.
Mr. Wälken joins AMP from Spectrum Therapeutics, a brand o... Read More...
Cannabis Shipment Volume Over First Two Months of Third Quarter ~20% Higher Than Cannabis Shipment Volume Over Entire Second QuarterVANCOUVER, BC, Aug. 31, 2020 - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced that its first shipments to Australia from its Zenabis Atholville facility was completed on August 2... Read More...
ERFURT and BERLIN, Germany and TORONTO, Aug. 11, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX: EEVVF) announce they have entered into a supply agreement for the purchase and export to Germany of European Union Good Manufacturing... Read More...
ERFURT and BERLIN, Germany, Aug. 4, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German... Read More...
ERFURT and BERLIN, Germany, July 21, 2020 - AMP German Cannabis Group Inc. ("AMP") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical cannabis. AMP will be purchasing and importing to Germany, 50 kil... Read More...
ERFURT and BERLIN, Germany, July 6, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will r... Read More...
ERFURT and BERLIN, Germany , June 29, 2020 - AMP German Cannabis Group Inc. ("AMP") (C4T.F) (ISIN:CA00176G1028) (XCX.CN) held its annual general meeting of shareholders (AGM) earlier today. The shareholders approved all resolutions put before them, namely:Re-electing Dr. Stefan Feuerstein and Messrs. Alex Blodgett , Claudio Morandi and Ke... Read More...
AMP is fully licenced to import medical cannabis from Europe and other countries
Building brands for the German medical cannabis market supplied by foreign licenced producers
Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand
ERFURT, Germany and BERLIN, June 8, 2020 - AMP German Cannabis Group Inc. ("... Read More...
ERFURT, Germany and BERLIN , June 2, 2020 - AMP German Cannabis Group Inc. ("AMP") (XCX.CN) (FSE: C4T, ISIN: CA00176G1028) will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29 th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online que... Read More...
BERLIN, April 14, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is pleased to announce it has successfully obtained all the required licences to import, store at its licensed narcotic storage facility and distribute to its pharmaceutical distributors irradiated EU-GMP certified medical cannabis fl... Read More...
BERLIN, March 9, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces that the Thuringian State Office for Consumer Protection or Thüringer Landesamt für Verbraucherschutz, ("TLV") has granted an additional import licence for cannabis products for medical purposes from European countries to Ger... Read More...
BERLIN , Jan. 15, 2020 - AMP German Cannabis Group Inc. ("AMP") (XCX.CN), ( Frankfurt : C4T, ISIN: CA00176G1028) provides an update on its strategy to become one of the leading importers of European Union - Good Manufacturing Practices (EU-GMP) medical cannabis into Germany through its network of suppliers from Canada , Europe and other n... Read More...
BERLIN and ERFURT, Germany, Nov. 18, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) ("TLV") has granted an import licence for cannabis products for medical purposes for Germany accordi... Read More...
AMP to supply the growing Germany market with pharmaceutical medical cannabis imported from Canada
ERFURT, Germany and BERLIN, Oct. 15, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) through its wholly-owned subsidiary AMP Alternative Medical Products GmbH ("AMP Germany") has entered into a ... Read More...
BERLIN, Oct. 10, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has begun conducting an European Union (EU) Good Manufacturing Procedure (EU-GMP) audit of its supply chain logistics in Germany to ensure that the quality and integrity of pharmaceutical goods during transport... Read More...
BERLIN, Oct. 8, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labeled European Union - Good Manufacturing Practice (EU-GMP) medical cannabis flower annua... Read More...
BERLIN, Sept. 17, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that one of its prospective medical cannabis supplier, Pure Life Cannabis Corp. ("Pure Life"), has completed its European Union Good Manufacturing Practice ("EU-GMP") gap analysis and will und... Read More...
BERLIN, Sept. 6, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 2,123,779 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, includin... Read More...
